Your browser doesn't support javascript.
loading
Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial.
Thouy, François; Bohé, Julien; Souweine, Bertrand; Abidi, Hassane; Quenot, Jean-Pierre; Thiollière, Fabrice; Dellamonica, Jean; Preiser, Jean-Charles; Timsit, Jean-François; Brunot, Vincent; Klich, Amna; Sedillot, Nicholas; Tchenio, Xavier; Roudaut, Jean-Baptiste; Mottard, Nicolas; Hyvernat, Hervé; Wallet, Florent; Danin, Pierre-Eric; Badie, Julio; Jospe, Richard; Morel, Jérôme; Mofredj, Ali; Fatah, Abdelhamid; Drai, Jocelyne; Mialon, Anne; Ait Hssain, Ali; Lautrette, Alexandre; Fontaine, Eric; Vacheron, Charles-Hervé; Maucort-Boulch, Delphine; Klouche, Kada; Dupuis, Claire.
Afiliación
  • Thouy F; Service de Médecine Intensive Réanimation, CHU Hôpital Gabriel-Montpied, 58 rue Montalembert, 63000, Clermont Ferrand, France.
  • Bohé J; Service d'Anesthésie-Réanimation-Médecine Intensive, Groupement hospitalier sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Souweine B; Service de Médecine Intensive Réanimation, CHU Hôpital Gabriel-Montpied, 58 rue Montalembert, 63000, Clermont Ferrand, France.
  • Abidi H; Service d'Anesthésie-Réanimation-Médecine Intensive, Groupement hospitalier sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Quenot JP; Service de Médecine Intensive Réanimation, CHU Dijon Bourgogne, Dijon, France.
  • Thiollière F; Service d'Anesthésie-Réanimation-Médecine Intensive, Groupement hospitalier sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Dellamonica J; Service de Médecine Intensive Réanimation, CHU Hôpital de L'Archet, Nice, France.
  • Preiser JC; UR2CA Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur, Nice, France.
  • Timsit JF; Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Brunot V; Service de Réanimation Médicale et des Maladies Infectieuses, Université Paris Diderot/Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Klich A; Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire, Montpellier, France.
  • Sedillot N; Service de Biostatistique - Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
  • Tchenio X; UMR5558, Laboratoire de Biométrie Et Biologie Évolutive, Équipe Biostatistique-Santé, CNRS, Villeurbanne, France.
  • Roudaut JB; Service de Réanimation, Hôpital Fleyriat, Bourg en Bresse, France.
  • Mottard N; Service de Réanimation, Hôpital Fleyriat, Bourg en Bresse, France.
  • Hyvernat H; Service de Médecine Intensive Réanimation, CHU Dijon Bourgogne, Dijon, France.
  • Wallet F; Service d'Anesthésie-Réanimation-Médecine Intensive, Groupement hospitalier sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Danin PE; Service de Médecine Intensive Réanimation, CHU Hôpital de L'Archet, Nice, France.
  • Badie J; Service d'Anesthésie-Réanimation-Médecine Intensive, Groupement hospitalier sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Jospe R; Service de Réanimation Médico-Chirurgicale, CHU Hôpital de L'Archet, Nice, France.
  • Morel J; Service de Réanimation Médico-Chirurgicale, CHU Hôpital de L'Archet, Nice, France.
  • Mofredj A; Département d'Anesthésie et Réanimation, CHU, Saint Etienne, France.
  • Fatah A; Département d'Anesthésie et Réanimation, CHU, Saint Etienne, France.
  • Drai J; Service de Réanimation, Hôpital du pays Salonais, Salon de Provence, France.
  • Mialon A; Service de Réanimation, Hôpital Pierre Oudot, Bourgoin Jallieu, France.
  • Ait Hssain A; Laboratoire de Biochimie, Groupement Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
  • Lautrette A; Laboratoire de Biochimie, Groupement Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
  • Fontaine E; Service de Médecine Intensive Réanimation, CHU Hôpital Gabriel-Montpied, 58 rue Montalembert, 63000, Clermont Ferrand, France.
  • Vacheron CH; Département d'Anesthésie et Réanimation, Centre Jean Perrin, Clermont Ferrand, France.
  • Maucort-Boulch D; INSERM U1055 - LBFA, University Grenoble Alpes, Grenoble, France.
  • Klouche K; Service d'Anesthésie-Réanimation-Médecine Intensive, Groupement hospitalier sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Dupuis C; Service de Biostatistique - Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Crit Care ; 26(1): 138, 2022 05 16.
Article en En | MEDLINE | ID: mdl-35578303
ABSTRACT

BACKGROUND:

Stress hyperglycemia can persist during an intensive care unit (ICU) stay and result in prolonged requirement for insulin (PRI). The impact of PRI on ICU patient outcomes is not known. We evaluated the relationship between PRI and Day 90 mortality in ICU patients without previous diabetic treatments.

METHODS:

This is a post hoc analysis of the CONTROLING trial, involving 12 French ICUs. Patients in the personalized glucose control arm with an ICU length of stay ≥ 5 days and who had never previously received diabetic treatments (oral drugs or insulin) were included. Personalized blood glucose targets were estimated on their preadmission usual glycemia as estimated by their glycated A1c hemoglobin (HbA1C). PRI was defined by insulin requirement. The relationship between PRI on Day 5 and 90-day mortality was assessed by Cox survival models with inverse probability of treatment weighting (IPTW). Glycemic control was defined as at least one blood glucose value below the blood glucose target value on Day 5.

RESULTS:

A total of 476 patients were included, of whom 62.4% were male, with a median age of 66 (54-76) years. Median values for SAPS II and HbA1C were 50 (37.5-64) and 5.7 (5.4-6.1)%, respectively. PRI was observed in 364/476 (72.5%) patients on Day 5. 90-day mortality was 23.1% in the whole cohort, 25.3% in the PRI group and 16.1% in the non-PRI group (p < 0.01). IPTW analysis showed that PRI on Day 5 was not associated with Day 90 mortality (IPTWHR = 1.22; CI 95% 0.84-1.75; p = 0.29), whereas PRI without glycemic control was associated with an increased risk of death at Day 90 (IPTWHR = 3.34; CI 95% 1.26-8.83; p < 0.01).

CONCLUSION:

In ICU patients without previous diabetic treatments, only PRI without glycemic control on Day 5 was associated with an increased risk of death. Additional studies are required to determine the factors contributing to these results.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_endocrine_disorders Asunto principal: Enfermedad Crítica / Hiperglucemia / Insulina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Crit Care Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_endocrine_disorders Asunto principal: Enfermedad Crítica / Hiperglucemia / Insulina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Crit Care Año: 2022 Tipo del documento: Article País de afiliación: Francia
...